These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 24886692

  • 21. Optimisation of spray drying process conditions for sugar nanoporous microparticles (NPMPs) intended for inhalation.
    Amaro MI, Tajber L, Corrigan OI, Healy AM.
    Int J Pharm; 2011 Dec 12; 421(1):99-109. PubMed ID: 21963473
    [Abstract] [Full Text] [Related]

  • 22. Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.
    Duan J, Vogt FG, Li X, Hayes D, Mansour HM.
    Int J Nanomedicine; 2013 Dec 12; 8():3489-505. PubMed ID: 24092972
    [Abstract] [Full Text] [Related]

  • 23. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
    Corrigan DO, Corrigan OI, Healy AM.
    Int J Pharm; 2006 Sep 28; 322(1-2):22-30. PubMed ID: 16815654
    [Abstract] [Full Text] [Related]

  • 24. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 25. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H, Young PM, Chan HK, Agus H, Traini D.
    Eur J Pharm Sci; 2010 Jun 14; 40(3):239-47. PubMed ID: 20371286
    [Abstract] [Full Text] [Related]

  • 26. Capreomycin inhalable powders prepared with an innovative spray-drying technique.
    Schoubben A, Giovagnoli S, Tiralti MC, Blasi P, Ricci M.
    Int J Pharm; 2014 Jul 20; 469(1):132-9. PubMed ID: 24747443
    [Abstract] [Full Text] [Related]

  • 27. Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients.
    Akdag Cayli Y, Sahin S, Buttini F, Balducci AG, Montanari S, Vural I, Oner L.
    Drug Dev Ind Pharm; 2017 Aug 20; 43(8):1378-1389. PubMed ID: 28420285
    [Abstract] [Full Text] [Related]

  • 28. Preparation and characterisation of novel spray-dried nano-structured para-aminosalicylic acid particulates for pulmonary delivery: impact of ammonium carbonate on morphology, chemical composition and solid state.
    Gad S, Tajber L, Corrigan OI, Healy AM.
    J Pharm Pharmacol; 2012 Sep 20; 64(9):1264-74. PubMed ID: 22881439
    [Abstract] [Full Text] [Related]

  • 29. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
    Nolan LM, Li J, Tajber L, Corrigan OI, Healy AM.
    Int J Pharm; 2011 Feb 28; 405(1-2):36-46. PubMed ID: 21129460
    [Abstract] [Full Text] [Related]

  • 30. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
    Weers JG, Miller DP, Tarara TE.
    AAPS PharmSciTech; 2019 Feb 07; 20(3):103. PubMed ID: 30734187
    [Abstract] [Full Text] [Related]

  • 31. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
    Nolan LM, Tajber L, McDonald BF, Barham AS, Corrigan OI, Healy AM.
    Eur J Pharm Sci; 2009 Jul 12; 37(5):593-602. PubMed ID: 19463948
    [Abstract] [Full Text] [Related]

  • 32. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles.
    Marasini N, Sheikh Z, Wong CYJ, Hosseini M, Spicer PT, Young P, Xin Ong H, Traini D.
    Int J Pharm; 2022 Aug 25; 624():121989. PubMed ID: 35809834
    [Abstract] [Full Text] [Related]

  • 33. Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying.
    Sansone F, Aquino RP, Del Gaudio P, Colombo P, Russo P.
    Eur J Pharm Biopharm; 2009 May 25; 72(1):206-13. PubMed ID: 18996478
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology.
    Tse JY, Kadota K, Imakubo T, Uchiyama H, Tozuka Y.
    Eur J Pharm Sci; 2021 Jan 01; 156():105600. PubMed ID: 33075466
    [Abstract] [Full Text] [Related]

  • 35. Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.
    Matinkhoo S, Lynch KH, Dennis JJ, Finlay WH, Vehring R.
    J Pharm Sci; 2011 Dec 01; 100(12):5197-205. PubMed ID: 22020816
    [Abstract] [Full Text] [Related]

  • 36. Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler: In-Vitro Characterization and In-Vivo Toxicological Studies.
    Sahastrabudhe H, Kenjale P, Pokharkar V.
    Curr Drug Deliv; 2020 Dec 01; 17(8):703-710. PubMed ID: 32472998
    [Abstract] [Full Text] [Related]

  • 37. Leucine enhances aerosol performance of naringin dry powder and its activity on cystic fibrosis airway epithelial cells.
    Prota L, Santoro A, Bifulco M, Aquino RP, Mencherini T, Russo P.
    Int J Pharm; 2011 Jun 30; 412(1-2):8-19. PubMed ID: 21459138
    [Abstract] [Full Text] [Related]

  • 38. Investigation of the dynamic process during spray-drying to improve aerodynamic performance of inhalation particles.
    Kawakami K, Sumitani C, Yoshihashi Y, Yonemochi E, Terada K.
    Int J Pharm; 2010 May 10; 390(2):250-9. PubMed ID: 20170721
    [Abstract] [Full Text] [Related]

  • 39. Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery.
    Silva DM, Paleco R, Traini D, Sencadas V.
    Int J Pharm; 2018 Aug 25; 547(1-2):114-121. PubMed ID: 29803795
    [Abstract] [Full Text] [Related]

  • 40. Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy.
    Buttini F, Balducci AG, Colombo G, Sonvico F, Montanari S, Pisi G, Rossi A, Colombo P, Bettini R.
    Int J Pharm; 2018 Sep 05; 548(1):182-191. PubMed ID: 29883795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.